CRBP - Corbus Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

CRBP is currently covered by 6 analysts with an average price target of $35. This is a potential upside of $31.99 (1062.79%) from yesterday's end of day stock price of $3.01.

Corbus Pharmaceuticals's activity chart (see below) currently has 81 price targets and 83 ratings on display. The stock rating distribution of CRBP is 100% BUY.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 18.54% of the time, taking 102.64 days on average.

Highest price target for CRBP is $52, Lowest price target is $23, average price target is $35.

Most recent stock forecast was given by GRAIG SUVANNAVEJH from MIZUHO. First documented stock forecast 05-Oct-2016.

Best performing analysts who are covering CRBP - Corbus Pharmaceuticals:

Andrew Fein Jeff Jones James Edwardes Jones Maury Raycroft Elemer Piros Laura Chico

Currently out of the existing stock ratings of CRBP, 15 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 23-Sep-2024

$23

$19.61 (578.47%)

$34

6 days ago
(12-Nov-2026)

Buy Since 07-Dec-2018

$33

$29.61 (873.45%)

$53

7 days ago
(11-Nov-2026)

1/11 (9.09%)

$29.07 (739.69%)

154

Buy Since 20-Sep-2024

$27

$23.61 (696.46%)

$30

7 days ago
(11-Nov-2026)

0/4 (0%)

$23.07 (587.02%)

Buy Since 12-Mar-2025

$35

$31.61 (932.45%)

$35

2 months 4 days ago
(14-Sep-2026)

0/7 (0%)

$26.92 (333.17%)

Buy Since 10-May-2023

$48

$44.61 (1315.93%)

$52

3 months 11 days ago
(07-Aug-2026)

5/16 (31.25%)

$37.83 (371.98%)

152

Show more analysts

Please expand the browser size to see the chart

What is CRBP (Corbus Pharmaceuticals) average time for price targets to be met?

On average it took 103 days for the stock forecasts to be reached, with an average price target met ratio of 18.54%.

Which analyst most recently updated their price target on CRBP (Corbus Pharmaceuticals)?

Graig Suvannavejh

Which analyst has the most public recommendations on CRBP (Corbus Pharmaceuticals)?

Graig Suvannavejh works at MIZUHO and has 13 price targets and 7 ratings on CRBP

Which analyst is the currently most bullish on CRBP (Corbus Pharmaceuticals)?

Christopher Marai with the highest potential upside of $956.61

Which analyst is the currently most reserved on CRBP (Corbus Pharmaceuticals)?

James Edwardes Jones with the lowest potential downside of -$13
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?